MedTrace Logo

Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial Fibrillation

NCT02507986 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2022-08-18

No results posted yet for this study

Summary

The main objective of this study is to compare the incidence of detected atrial fibrillation (AF) in cryptogenic stroke patients by a single lead ECG device with the incidence of detected AF by a 7-Day Holter ECG.

Conditions

Interventions

DEVICE

Single lead ECG device

The single lead ECG device is a smartphone compatible handheld device that produces a single lead ECG after 30 seconds of measurement. It is non-invasive, electrically safe and easy to use.

DEVICE

7-Day Holter monitor.

The Holter is a conventional 7-Day Holter monitor.

Sponsors & Collaborators

  • Medical Center Haaglanden

    collaborator OTHER

  • Groene Hart Ziekenhuis

    collaborator OTHER

  • Herning Hospital

    collaborator OTHER

  • Alrijne Hospital

    collaborator OTHER

  • Reinier de Graaf Groep

    collaborator OTHER

  • Leiden University

    lead OTHER

Principal Investigators

  • Serge Trines, MD, PhD · Leiden University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-29
Primary Completion
2022-01-04
Completion
2022-01-04

Countries

  • Denmark
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02507986 on ClinicalTrials.gov